| Revenue | SEK 1,5M | -67% |
| EBITDA | SEK -8,9M | -598% |
| Net profit | SEK 248,9M | +2535% |
| Total assets | SEK 251,9M | +691% |
| Equity | SEK 251M | +2983% |
| Employees | 0 | — |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 700 | 3 000 | 3 027 | 4 500 | 1 500 |
| Staff expenses | — | — | — | — | −1 720 |
| EBITDA | 356 | 1 510 | 1 393 | −1 281 | −8 939 |
| Depreciation & amort. | −3 | −3 | −0 | −0 | — |
| EBIT | 353 | 1 507 | 1 393 | −1 281 | −8 939 |
| Net financials | — | — | — | 9 736 | 257 804 |
| Profit before tax | 401 | 1 172 | 1 010 | 9 448 | 248 865 |
| Tax | −98 | −262 | −237 | −4 | — |
| Net profit | 303 | 910 | 773 | 9 444 | 248 865 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 986 | 2 115 | 3 199 | 31 844 | 251 870 |
| Equity | 558 | 1 118 | 1 641 | 8 142 | 251 007 |
| Long-term debt | 0 | 0 | 0 | 0 | — |
| Short-term debt | 1 153 | 387 | 565 | 23 702 | 863 |
| Total debt | 1 153 | 387 | 565 | 23 702 | 863 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
SJ | Audit | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2024 | |
| Deputy Board Member | 2022 | |
| Former (2) | ||
| Board of Directors | 2024 – 2025 | |
| Board of Directors | 2024 – 2025 | |
No shareholder data available.
| Person | Role here | Other companies |
|---|---|---|
| Sten Johan Pharmanson | Audit | 0 companies |
| Johan Ludvig Amnéus | Chairman | 0 companies |
| Mats Pål Jernhag | Board of Directors | 0 companies |
| Maria Ann-Louise Amnéus | Deputy Board Member | 0 companies |
| Robert Klatskow | Board of Directors | 0 companies |